메뉴 건너뛰기




Volumn 28, Issue 6, 2005, Pages 469-480

The Pathophysiology of Chemotherapy‐Induced Nausea and Vomiting

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT;

EID: 33645904828     PISSN: 1042895X     EISSN: 15389766     Source Type: Journal    
DOI: 10.1097/00001610-200511000-00003     Document Type: Article
Times cited : (37)

References (48)
  • 1
    • 0035162772 scopus 로고    scopus 로고
    • The gut as the largest endocrine organ in the body.
    • Ahlman, H., & Nilsson, O. (2001). The gut as the largest endocrine organ in the body. Annals of Oncology, 12(Suppl. 2), S63-S68.
    • (2001) Annals of Oncology , vol.12 , pp. S63-S68
    • Ahlman, H.1    Nilsson, O.2
  • 2
    • 0033561077 scopus 로고    scopus 로고
    • ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery.
    • American Society of Health-System Pharmacists (ASHP). (1999). ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery. American Journal of Health-System Pharmacy, 56(8), 729-764.
    • (1999) American Journal of Health-System Pharmacy , vol.56 , Issue.8 , pp. 729-764
  • 3
    • 85026135852 scopus 로고    scopus 로고
    • Andrews, P. L. R., & Davis, C. J. (1993). Chapter 7: The mechanism of emesis induced by anti-cancer therapies (113-161). In P. L. R. Andrews, & G. J. Sanger (Eds.), Emesis in anti-cancer therapy: Mechanisms and treatment. London: Chapman & Hall Medical.
    • Andrews, P. L. R., & Davis, C. J. (1993). Chapter 7: The mechanism of emesis induced by anti-cancer therapies (113-161). In P. L. R. Andrews, & G. J. Sanger (Eds.), Emesis in anti-cancer therapy: Mechanisms and treatment. London: Chapman & Hall Medical.
  • 4
    • 0031900769 scopus 로고    scopus 로고
    • Neuropharmacology of emesis and its relevance to anti-emetic therapy: Consensus and controversies.
    • Andrews, P. L. R., Naylor, R. J., & Joss, R. A. (1998). Neuropharmacology of emesis and its relevance to anti-emetic therapy: Consensus and controversies. Supportive Care in Cancer, 6(3), 197-203.
    • (1998) Supportive Care in Cancer , vol.6 , Issue.3 , pp. 197-203
    • Andrews, P.L.R.1    Naylor, R.J.2    Joss, R.A.3
  • 6
    • 77049144409 scopus 로고
    • Physiology and pharmacology of vomiting.
    • Borison, H. L., & Wang, S. C. (1953). Physiology and pharmacology of vomiting. Pharmacological Review, 5(5), 193-220.
    • (1953) Pharmacological Review , vol.5 , Issue.5 , pp. 193-220
    • Borison, H.L.1    Wang, S.C.2
  • 7
    • 0027078370 scopus 로고
    • Mechanisms by which cancer chemotherapeutic drugs induce emesis.
    • Cubeddu, L. X. (1992). Mechanisms by which cancer chemotherapeutic drugs induce emesis. Seminars in Oncology, 19(Suppl 15), 2-13.
    • (1992) Seminars in Oncology , vol.19 , pp. 2-13
    • Cubeddu, L.X.1
  • 8
    • 1842790093 scopus 로고    scopus 로고
    • Aprepitent: A review of its use in the prevention of chemotherapy-induced nausea and vomiting.
    • Dando, T. M., & Perry, C. M. (2004). Aprepitent: A review of its use in the prevention of chemotherapy-induced nausea and vomiting. Drugs, 64(7), 777-794.
    • (2004) Drugs , vol.64 , Issue.7 , pp. 777-794
    • Dando, T.M.1    Perry, C.M.2
  • 9
    • 0037561044 scopus 로고    scopus 로고
    • Current position of 5-HT3 antagonists and the additional value of NK1 antagonists: A new class of antiemetics.
    • 1 antagonists: A new class of antiemetics. British Journal of Cancer, 88(12), 1823-1827.
    • (2003) British Journal of Cancer , vol.88 , Issue.12 , pp. 1823-1827
    • de Wit, R.1
  • 10
    • 0346556083 scopus 로고    scopus 로고
    • 1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. Journal of Clinical Oncology, 21(22), 4105-4111.
    • 1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy. Journal of Clinical Oncology, 21(22), 4105-4111.
  • 11
    • 0033774032 scopus 로고    scopus 로고
    • Potential of substance P antagonists as antiemetics.
    • Diemunsch, P., & Grelot, L. (2000). Potential of substance P antagonists as antiemetics. Drugs, 60(3), 533-546.
    • (2000) Drugs , vol.60 , Issue.3 , pp. 533-546
    • Diemunsch, P.1    Grelot, L.2
  • 12
    • 0141761458 scopus 로고    scopus 로고
    • Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children.
    • Dupuis, L. L., & Nathan, P. C. (2003). Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children. Pediatric Drugs, 5(9), 597-613.
    • (2003) Pediatric Drugs , vol.5 , Issue.9 , pp. 597-613
    • Dupuis, L.L.1    Nathan, P.C.2
  • 14
    • 33748747008 scopus 로고    scopus 로고
    • Chemotherapy-induced nausea vomiting: Research update on improving control.
    • Fromer, M. J. (2005). Chemotherapy-induced nausea & vomiting: Research update on improving control. Oncology Times, 27(1), 19-23.
    • (2005) Oncology Times , vol.27 , Issue.1 , pp. 19-23
    • Fromer, M.J.1
  • 15
    • 0033550693 scopus 로고    scopus 로고
    • The site of the anti-emetic action of tachykinin NK1 receptor antagonists may exist in the medullary area adjacent to the semicompact part of the nucleus ambiguus.
    • Fukunda, H., Nakamura, E., Koga, T., Furukawa, N., & Shiroshita, Y. (1999). The site of the anti-emetic action of tachykinin NK1 receptor antagonists may exist in the medullary area adjacent to the semicompact part of the nucleus ambiguus. Brain Research, 818(2), 439-449.
    • (1999) Brain Research , vol.818 , Issue.2 , pp. 439-449
    • Fukunda, H.1    Nakamura, E.2    Koga, T.3    Furukawa, N.4    Shiroshita, Y.5
  • 16
    • 0036413427 scopus 로고    scopus 로고
    • 5-HT3-receptor antagonists for the treatment of nausea and nausea and vomiting: A reappraisal of their side-effect profile.
    • 3-receptor antagonists for the treatment of nausea and nausea and vomiting: A reappraisal of their side-effect profile. Oncologist, 7(5), 424-436.
    • (2002) Oncologist , vol.7 , Issue.5 , pp. 424-436
    • Goodin, S.1    Cunningham, R.2
  • 17
    • 0036124257 scopus 로고    scopus 로고
    • Gralla, R. J. (2002). New agents, new treatment, and antiemetic therapy. Seminars in Oncology, 29(1, Suppl 4), 199-124.
    • Gralla, R. J. (2002). New agents, new treatment, and antiemetic therapy. Seminars in Oncology, 29(1, Suppl 4), 199-124.
  • 18
    • 0032847992 scopus 로고    scopus 로고
    • Gralla, R. J., Osoba, D., Kris, M. G., Kirkbride, P., Hesketh, P. J., Chinnery, L. W., et al. (1999). Recommendations for the use of antiemetics: Evidence-based clinical practice guidelines. Journal of Clinical Oncology, 17(9), 2971-2994.
    • Gralla, R. J., Osoba, D., Kris, M. G., Kirkbride, P., Hesketh, P. J., Chinnery, L. W., et al. (1999). Recommendations for the use of antiemetics: Evidence-based clinical practice guidelines. Journal of Clinical Oncology, 17(9), 2971-2994.
  • 19
    • 16644388026 scopus 로고    scopus 로고
    • New developments in the management of chemotherapy-induced emesis: Do they impact on existing guidelines? Oncology, 18(10 Suppl.
    • Grunberg, S. M. (2004). New developments in the management of chemotherapy-induced emesis: Do they impact on existing guidelines? Oncology, 18(10 Suppl.), 15-19.
    • (2004) , vol.15 , pp. 19
    • Grunberg, S.M.1
  • 20
    • 16644377501 scopus 로고    scopus 로고
    • Understanding the pathobiology of chemotherapy-induced nausea and vomiting: Providing a basis for therapeutic progress. Oncology, 18(10 Suppl.
    • Hesketh, P. J. (2004). Understanding the pathobiology of chemotherapy-induced nausea and vomiting: Providing a basis for therapeutic progress. Oncology, 18(10 Suppl.), 9-14.
    • (2004) , vol.9 , pp. 14
    • Hesketh, P.J.1
  • 21
    • 0347816226 scopus 로고    scopus 로고
    • Hesketh, P. J., Grunberg, S. M., Gralla, R. J., Warr, D. G., Roila, F., de Wit, R., et al. (2003). The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin-The aprepitant protocol 052 study group. Journal of Clinical Oncology, 21(22), 4112-4119.
    • Hesketh, P. J., Grunberg, S. M., Gralla, R. J., Warr, D. G., Roila, F., de Wit, R., et al. (2003). The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: A multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin-The aprepitant protocol 052 study group. Journal of Clinical Oncology, 21(22), 4112-4119.
  • 22
    • 0031025087 scopus 로고    scopus 로고
    • Hesketh, P. J., Kris, M. G., Grunberg, S. M., Beck, T., Hainsworth, J. D., Harker, G., et al. (1997). Proposal for classifying the acute emetogenicity of cancer chemotherapy. Journal of Clinical Oncology, 15(1), 103-109.
    • Hesketh, P. J., Kris, M. G., Grunberg, S. M., Beck, T., Hainsworth, J. D., Harker, G., et al. (1997). Proposal for classifying the acute emetogenicity of cancer chemotherapy. Journal of Clinical Oncology, 15(1), 103-109.
  • 23
    • 0025455312 scopus 로고
    • Patterns of nausea and vomiting in children: Nursing assessment and intervention.
    • Hockenberry-Eaton, M., & Benner, A. (1990). Patterns of nausea and vomiting in children: Nursing assessment and intervention. Oncology Nursing Forum, 17(4), 575-584.
    • (1990) Oncology Nursing Forum , vol.17 , Issue.4 , pp. 575-584
    • Hockenberry-Eaton, M.1    Benner, A.2
  • 24
    • 0031204451 scopus 로고    scopus 로고
    • Physiologic mechanisms of nausea and vomiting in patients with cancer.
    • Hogan, C. M., & Grant, M. (1997). Physiologic mechanisms of nausea and vomiting in patients with cancer. Oncology Nursing Forum, 24(7), 8-12.
    • (1997) Oncology Nursing Forum , vol.24 , Issue.7 , pp. 8-12
    • Hogan, C.M.1    Grant, M.2
  • 25
    • 0033253113 scopus 로고    scopus 로고
    • Self-regulation theory and coping with physical illness.
    • Johnson, J. E. (1999). Self-regulation theory and coping with physical illness. Research in Nursing & Health, 22(6), 435-448.
    • (1999) Research in Nursing Health , vol.22 , Issue.6 , pp. 435-448
    • Johnson, J.E.1
  • 26
    • 0031204801 scopus 로고    scopus 로고
    • Nonpharmacologic management of chemotherapy-induced nausea and vomiting.
    • King, C. R. (1997). Nonpharmacologic management of chemotherapy-induced nausea and vomiting. Oncology Nursing Forum, 24(Suppl. 7), S41-S48.
    • (1997) Oncology Nursing Forum , vol.24 , pp. S41-S48
    • King, C.R.1
  • 27
    • 0036933329 scopus 로고    scopus 로고
    • Koeller, J. M., Aapro, M. S., Gralla, R. S., Grunberg, S. M., Hesketh, P. J., Kris, M. G., et al. (2002). Antiemetic guidelines: Creating a more practical treatment approach. Supportive Care of Cancer, 10(7), 519-522.
    • Koeller, J. M., Aapro, M. S., Gralla, R. S., Grunberg, S. M., Hesketh, P. J., Kris, M. G., et al. (2002). Antiemetic guidelines: Creating a more practical treatment approach. Supportive Care of Cancer, 10(7), 519-522.
  • 28
    • 85026153606 scopus 로고    scopus 로고
    • Leslie, R. A., & Reynolds, D. J. M. (1993). Chapter 6: Neurotransmitters and receptors in the emetic pathway. In P. L. R. Andrews, & G. J. Sanger (Eds.), Emesis in anti-cancer therapy. London: Chapman & Hall Medical.
    • Leslie, R. A., & Reynolds, D. J. M. (1993). Chapter 6: Neurotransmitters and receptors in the emetic pathway. In P. L. R. Andrews, & G. J. Sanger (Eds.), Emesis in anti-cancer therapy. London: Chapman & Hall Medical.
  • 29
    • 0042787587 scopus 로고    scopus 로고
    • Antiemetic therapy in patients receiving cancer chemotherapy.
    • Marek, C. (2003). Antiemetic therapy in patients receiving cancer chemotherapy. Oncology Nursing Forum, 30(2), 259-269.
    • (2003) Oncology Nursing Forum , vol.30 , Issue.2 , pp. 259-269
    • Marek, C.1
  • 30
    • 0031255395 scopus 로고    scopus 로고
    • Controlling conditioning-related emesis in children undergoing bone marrow transplantation.
    • Mehta, N. H., Reed, C. M., Kuhlman, C., Weinstein, H. J., & Parsons, S. K. (1997). Controlling conditioning-related emesis in children undergoing bone marrow transplantation. Oncology Nursing Forum, 24(9), 1539-1544.
    • (1997) Oncology Nursing Forum , vol.24 , Issue.9 , pp. 1539-1544
    • Mehta, N.H.1    Reed, C.M.2    Kuhlman, C.3    Weinstein, H.J.4    Parsons, S.K.5
  • 31
    • 0038175313 scopus 로고    scopus 로고
    • Improving the care of patients with regard to chemotherapy-induced nausea and emesis: The effect of feedback to clinicians on adherence to antiemetic presenting guidelines.
    • Mertens, W. C., Higby, D. J., Brown, D., Parisi, R., Fitzgerald, J., Benjamin, E. M., & Lindenauer, P. K. (2003). Improving the care of patients with regard to chemotherapy-induced nausea and emesis: The effect of feedback to clinicians on adherence to antiemetic presenting guidelines. Journal of Clinical Oncology, 21(7), 1373-1378.
    • (2003) Journal of Clinical Oncology , vol.21 , Issue.7 , pp. 1373-1378
    • Mertens, W.C.1    Higby, D.J.2    Brown, D.3    Parisi, R.4    Fitzgerald, J.5    Benjamin, E.M.6    Lindenauer, P.K.7
  • 32
    • 0021247694 scopus 로고
    • The assessment of nausea and vomiting: Past problems, current issues, and suggestions for future research.
    • Morrow, G. R. (1984). The assessment of nausea and vomiting: Past problems, current issues, and suggestions for future research. Cancer, 53(Suppl. 10), 2267-2278.
    • (1984) Cancer , vol.53 , pp. 2267-2278
    • Morrow, G.R.1
  • 33
    • 85026135560 scopus 로고    scopus 로고
    • Retrieved May 9, 2003, from
    • Morrow, G. R. (2003). Chemotherapy-related nausea and vomiting. In M. B. Max & J. Lynn (Eds.), Interactive textbook on clinical management. (Online at Symptom Research Interactive Research Textbook website).
  • 35
    • 0031691344 scopus 로고    scopus 로고
    • Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus Conference.
    • Multinational Association of Supportive Care in Cancer (MASCC), Antiemetics Subcommittee. (1998). Prevention of chemotherapy- and radiotherapy-induced emesis: Results of the Perugia Consensus Conference. Annals of Oncology, 9(8), 811-819.
    • (1998) Annals of Oncology , vol.9 , Issue.8 , pp. 811-819
  • 36
    • 85026148144 scopus 로고    scopus 로고
    • Retrieved September 30, 2002, from
    • National Comprehensive Cancer Network (NCCN) Antiemesis Panel. (2001, January 30). Antiemesis; version 1.2001. NCCN: Practice guidelines in oncology.
  • 37
    • 0029788231 scopus 로고    scopus 로고
    • Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models.
    • Naylor, R. J., & Rudd, J. A. (1996). Mechanisms of chemotherapy/radiotherapy-induced emesis in animal models. Oncology, 53(Suppl. 1), 8-17.
    • (1996) Oncology , vol.53 , pp. 8-17
    • Naylor, R.J.1    Rudd, J.A.2
  • 38
    • 1842590585 scopus 로고    scopus 로고
    • Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomiting.
    • Olver, I. N. (2004). Aprepitant in antiemetic combinations to prevent chemotherapy-induced nausea and vomiting. International Journal of Clinical Practice, 58(2), 201-206.
    • (2004) International Journal of Clinical Practice , vol.58 , Issue.2 , pp. 201-206
    • Olver, I.N.1
  • 39
    • 85026142711 scopus 로고    scopus 로고
    • Purl, S., & Wickham, R. (2002). Managing chemotherapy-related nausea: Evidence-based approaches. (Workbook for interactive audioconference, ROC-9). Monmouth Junction, NJ: Interactive Network for Continuing Education.
    • Purl, S., & Wickham, R. (2002). Managing chemotherapy-related nausea: Evidence-based approaches. (Workbook for interactive audioconference, ROC-9). Monmouth Junction, NJ: Interactive Network for Continuing Education.
  • 40
    • 0033146925 scopus 로고    scopus 로고
    • The index of nausea, vomiting, and retching: A new format of the index of nausea and vomiting.
    • Rhodes, V. A., & McDaniel, R. W. (1999). The index of nausea, vomiting, and retching: A new format of the index of nausea and vomiting. Oncology Nursing Forum, 26(5), 889-894.
    • (1999) Oncology Nursing Forum , vol.26 , Issue.5 , pp. 889-894
    • Rhodes, V.A.1    McDaniel, R.W.2
  • 41
  • 42
    • 85026140696 scopus 로고    scopus 로고
    • Rudd, J. A., & Andrews, P. L. R. (2005). Chapter 2: Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In P. J. Hesketh (Ed.), Management of nausea and vomiting in cancer and cancer treatment. Sudbury, MA: Jones and Bartlett Publishers.
    • Rudd, J. A., & Andrews, P. L. R. (2005). Chapter 2: Mechanisms of acute, delayed, and anticipatory emesis induced by anticancer therapies. In P. J. Hesketh (Ed.), Management of nausea and vomiting in cancer and cancer treatment. Sudbury, MA: Jones and Bartlett Publishers.
  • 43
    • 0037258090 scopus 로고    scopus 로고
    • Chemotherapy-induced nausea and vomiting: The importance of acute antiemetic control.
    • Schnell, F. M. (2003). Chemotherapy-induced nausea and vomiting: The importance of acute antiemetic control. Oncologist, 8(2), 187-198.
    • (2003) Oncologist , vol.8 , Issue.2 , pp. 187-198
    • Schnell, F.M.1
  • 44
    • 2942601362 scopus 로고    scopus 로고
    • Palonosetron.
    • Siddiqui, M. A. A., & Scott, L J. (2004). Palonosetron. Drugs, 64(10), 1125-1132.
    • (2004) Drugs , vol.64 , Issue.10 , pp. 1125-1132
    • Siddiqui, M.A.A.1    Scott, L.J.2
  • 45
    • 0037737739 scopus 로고    scopus 로고
    • The ups and downs of novel antiemetic drugs, part 1: Substance P, 5-HT, and the neuropharmacology of vomiting.
    • Stahl, S. M. (2003). The ups and downs of novel antiemetic drugs, part 1: Substance P, 5-HT, and the neuropharmacology of vomiting. Journal of Clinical Psychiatry, 64(5), 498-499.
    • (2003) Journal of Clinical Psychiatry , vol.64 , Issue.5 , pp. 498-499
    • Stahl, S.M.1
  • 46
    • 13844280916 scopus 로고    scopus 로고
    • Developments in antiemetic therapy.
    • Stenger, M. (2004). Developments in antiemetic therapy. Community Oncology, 1(2), 79-81.
    • (2004) Community Oncology , vol.1 , Issue.2 , pp. 79-81
    • Stenger, M.1
  • 47
    • 0031014883 scopus 로고    scopus 로고
    • Physiology of chemotherapy-induced emesis and antiemetic therapy: Predictive models for evaluation of new compounds.
    • Veyrat-Follet, C., Farinotti, R., & Palmer, J. L. (1997). Physiology of chemotherapy-induced emesis and antiemetic therapy: Predictive models for evaluation of new compounds. Drugs, 53(2), 206-234.
    • (1997) Drugs , vol.53 , Issue.2 , pp. 206-234
    • Veyrat-Follet, C.1    Farinotti, R.2    Palmer, J.L.3
  • 48
    • 85026155000 scopus 로고    scopus 로고
    • Wickham, R. (2003). Nausea and vomiting in cancer.
    • Wickham, R. (2003). Nausea and vomiting in cancer.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.